C07K 16/1207
From spirochaetales
Official title: {from Spirochaetales (O), e.g. Treponema, Leptospira}
C07K16/1207 (From spirochaetales) appears on 102 US grants and 80 published applications in this corpus.
Search patents in C07K- Granted patents
- 102
- Published applications
- 80
- Assignees
- 66
- Inventors
- 159
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 5 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 3 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 0 |
| 2002 | 3 | 1 |
| 2003 | 3 | 4 |
| 2004 | 8 | 6 |
| 2005 | 1 | 2 |
| 2006 | 3 | 1 |
| 2007 | 1 | 4 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 2 | 3 |
| 2011 | 3 | 5 |
| 2012 | 3 | 3 |
| 2013 | 2 | 3 |
| 2014 | 2 | 7 |
| 2015 | 4 | 5 |
| 2016 | 2 | 4 |
| 2017 | 4 | 5 |
| 2018 | 3 | 4 |
| 2019 | 3 | 2 |
| 2020 | 2 | 2 |
| 2021 | 2 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 4 |
| 2024 | 0 | 3 |
| 2025 | 2 | 1 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies27 Jan 2026US 12,535,481 B2Virginia Tech Intellectual Properties, Inc.
- Modified HIV-1 proviral vectors with enhanced dendritic cell transduction efficiencies comprising the JRFL envelope23 Dec 2025US 12,503,499 B2University of Massachusetts
- Mutant fragments of OspA and methods and uses relating thereto14 Jan 2025US 12,195,501 B2Valneva Austria GmbH
- Mutant fragments of OspA and methods and uses relating thereto7 Feb 2023US 11,572,392 B2Valneva Austria GmbH
- DbpA antibodies and uses thereof10 Jan 2023US 11,548,938 B2Quidel Corporation
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Use of modified hiv-1 for generating fully human antibodies2 Jul 2026US 2026/0184767 A1University of Massachusetts
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies4 Jun 2026US 2026/0153509 A1Virginia Tech Intellectual Properties, Inc.
- Mutant fragments of ospa and methods and uses relating thereto12 Mar 2026US 2026/0070950 A1Valneva Austria GmbH
- Borrelia burgdorferi peptidoglycan detection methods25 Sep 2025US 2025/0298019 A1Virginia Tech Intellectual Properties, Inc.
Most cited
By later US patents
- Vaccine against Lyme disease47US 5,178,859 ADeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts · 1993
- Method for detection of Borrelia burgdorferi antigens34US 5,217,872 AThe United States of America as represented by the Department of Health and Human Services · 1993
- Borrelia antigen33US 5,523,089 ASymbicom Aktiebolag · 1996
- Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP9032US 5,777,095 ASymbicom Aktiebolag · 1998
- Borrelia burdorferi Osp A and B proteins and immunogenic peptides29US 6,143,872 ASymbicom Aktiebolag · 2000